2 studies found for:    23846733 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Overweight
Interventions: Drug: Lorcaserin;   Drug: Metformin;   Drug: Placebo
2 Completed
Has Results
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
Condition: Schizophrenia
Interventions: Drug: Metformin;   Drug: Placebo

Indicates status has not been verified in more than two years